Ashfield Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $15.5M | Sell |
95,026
-991
| -1% | -$168K | 1.3% | 22 |
|
|
2022
Q2 | $17M | Sell |
96,017
-739
| -0.8% | -$132K | 1.33% | 20 |
|
|
2022
Q1 | $17.1M | Sell |
96,756
-485
| -0.5% | -$82.5K | 1.11% | 22 |
|
|
2021
Q4 | $16.6M | Sell |
97,241
-12
| -0% | -$1.97K | 1.07% | 24 |
|
|
2021
Q3 | $15.7M | Sell |
97,253
-895
| -0.9% | -$153K | 1.12% | 23 |
|
|
2021
Q2 | $16.2M | Buy |
98,148
+602
| +0.6% | +$99.7K | 1.15% | 22 |
|
|
2021
Q1 | $16M | Sell |
97,546
-1,154
| -1% | -$187K | 1.27% | 20 |
|
|
2020
Q4 | $15.5M | Sell |
98,700
-127
| -0.1% | -$18.7K | 1.26% | 20 |
|
|
2020
Q3 | $14.7M | Sell |
98,827
-565
| -0.6% | -$83.6K | 1.34% | 22 |
|
|
2020
Q2 | $14M | Sell |
99,392
-1,335
| -1% | -$195K | 1.38% | 21 |
|
|
2020
Q1 | $13.2M | Sell |
100,727
-543
| -0.5% | -$77K | 1.61% | 17 |
|
|
2019
Q4 | $14.8M | Sell |
101,270
-4,856
| -5% | -$659K | 1.47% | 19 |
|
|
2019
Q3 | $13.7M | Sell |
106,126
-518
| -0.5% | -$68.2K | 1.49% | 19 |
|
|
2019
Q2 | $14.9M | Sell |
106,644
-362
| -0.3% | -$50.1K | 1.59% | 15 |
|
|
2019
Q1 | $15M | Sell |
107,006
-444
| -0.4% | -$59.5K | 1.64% | 12 |
|
|
2018
Q4 | $13.9M | Buy |
107,450
+1,051
| +1% | +$147K | 1.81% | 10 |
|
|
2018
Q3 | $14.7M | Sell |
106,399
-1,997
| -2% | -$265K | 1.65% | 12 |
|
|
2018
Q2 | $13.2M | Sell |
108,396
-38
| -0% | -$4.74K | 1.64% | 12 |
|
|
2018
Q1 | $13.9M | Sell |
108,434
-430
| -0.4% | -$58.1K | 1.81% | 9 |
|
|
2017
Q4 | $15.2M | Sell |
108,864
-542
| -0.5% | -$75.5K | 1.96% | 8 |
|
|
2017
Q3 | $14.2M | Sell |
109,406
-114
| -0.1% | -$15.1K | 1.91% | 6 |
|
|
2017
Q2 | $14.5M | Sell |
109,520
-440
| -0.4% | -$56.1K | 1.98% | 5 |
|
|
2017
Q1 | $13.7M | Sell |
109,960
-668
| -0.6% | -$79.8K | 1.9% | 6 |
|
|
2016
Q4 | $12.7M | Sell |
110,628
-4,281
| -4% | -$495K | 1.25% | 23 |
|
|
2016
Q3 | $13.6M | Sell |
114,909
-339
| -0.3% | -$41.1K | 1.12% | 28 |
|
|
2016
Q2 | $14M | Sell |
115,248
-450
| -0.4% | -$51.1K | 1.12% | 29 |
|
|
2016
Q1 | $12.5M | Buy |
115,698
+2,125
| +2% | +$220K | 0.91% | 36 |
|
|
2015
Q4 | $11.7M | Sell |
113,573
-2,436
| -2% | -$245K | 0.8% | 43 |
|
|
2015
Q3 | $10.8M | Sell |
116,009
-4,014
| -3% | -$388K | 0.7% | 47 |
|
|
2015
Q2 | $11.7M | Sell |
120,023
-1,375
| -1% | -$138K | 0.64% | 49 |
|
|
2015
Q1 | $12.2M | Sell |
121,398
-888
| -0.7% | -$90.3K | 0.65% | 50 |
|
|
2014
Q4 | $12.8M | Sell |
122,286
-623
| -0.5% | -$65.7K | 0.62% | 51 |
|
|
2014
Q3 | $13.1M | Sell |
122,909
-667
| -0.5% | -$69.2K | 0.64% | 54 |
|
|
2014
Q2 | $12.9M | Sell |
123,576
-1,954
| -2% | -$198K | 0.61% | 56 |
|
|
2014
Q1 | $12.3M | Sell |
125,530
-11
| -0% | -$1.02K | 0.59% | 55 |
|
|
2013
Q4 | $11.5M | Buy |
125,541
+268
| +0.2% | +$24.7K | 0.55% | 55 |
|
|
2013
Q3 | $10.9M | Sell |
125,273
-252
| -0.2% | -$22.6K | 0.56% | 58 |
|
|
2013
Q2 | $10.8M | Buy |
+125,525
| New | +$10.7M | 0.58% | 59 |
|
Other funds holding JNJ
Ashfield Capital Partners's JNJ Position: Q3 2022 in Review
Ashfield Capital Partners reduced its Johnson & Johnson (JNJ) stake by 1% in Q3 2022, selling an estimated $168K and leaving 95,026 shares worth $15.5M. The position accounts for 1.3% of the portfolio, ranked #22.
Ashfield Capital Partners first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $17.1M in Q1 2022. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Ashfield Capital Partners held 95,026 shares of Johnson & Johnson worth $15.5M as of Q3 2022.
- Ashfield Capital Partners sold 991 Johnson & Johnson shares in Q3 2022, an estimated $168K.
- Johnson & Johnson made up 1.3% of Ashfield Capital Partners's portfolio in Q3 2022, its #22 holding.
- Ashfield Capital Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's Johnson & Johnson position peaked at $17.1M in Q1 2022.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.